GSK investigational MMRV vaccine shows comparable immunogenicity to licensed MMRV in healthy children
GSK MMRV vaccine shows comparable safety and immune response to licensed MMRV in young children
This randomized, multi-country phase II trial in 801 healthy children aged 4-6 years found that one dose of a GSK investigational MMRV vacci…
A Phase II trial in healthy children found the investigational GSK MMRV vaccine produced immune responses and safety similar to the licensed…
Mass vaccination campaign conducted among Afghan evacuees in US after measles cases
How did health officials respond to measles cases among Afghan evacuees?
A descriptive public health report details a mass vaccination campaign implemented among Afghan evacuees brought to the United States follow…
Public health officials launched a mass vaccination campaign to stop measles spread among Afghan evacuees arriving in the United States.